171 related articles for article (PubMed ID: 37894462)
1. Triage Strategies for Non-16/Non-18 HPV-Positive Women in Primary HPV-Based Cervical Cancer Screening: p16/Ki67 Dual Stain vs. Cytology.
Mazurec K; Trzeszcz M; Mazurec M; Streb J; Halon A; Jach R
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894462
[TBL] [Abstract][Full Text] [Related]
2. Should we use risk selection tests for HPV 16 and/or 18 positive cases: Comparison of p16/Ki67 and cytology.
Mazurec K; Trzeszcz M; Mazurec M; Streb J; Halon A; Jach R
J Med Virol; 2024 Mar; 96(3):e29500. PubMed ID: 38440951
[TBL] [Abstract][Full Text] [Related]
3. Is Primary HPV with Secondary p16/Ki67 Dual-Stain an Alternative HSIL-Risk Detection Strategy in Cervical Cancer Screening for Women under 30 Years?
Trzeszcz M; Mazurec M; Jach R; Mazurec K; Jach Z; Kotkowska-Szeps I; Kania M; Wantuchowicz M; Prokopyk A; Barcikowski P; Przybylski M; Wach J; Halon A
Diagnostics (Basel); 2021 Oct; 11(11):. PubMed ID: 34829358
[TBL] [Abstract][Full Text] [Related]
4. Five-Year Risk of Cervical Precancer Following p16/Ki-67 Dual-Stain Triage of HPV-Positive Women.
Clarke MA; Cheung LC; Castle PE; Schiffman M; Tokugawa D; Poitras N; Lorey T; Kinney W; Wentzensen N
JAMA Oncol; 2019 Feb; 5(2):181-186. PubMed ID: 30325982
[TBL] [Abstract][Full Text] [Related]
5. [Clinical value of p16
Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
[No Abstract] [Full Text] [Related]
6. Clinical validation of p16/Ki-67 dual-stained cytology triage of HPV-positive women: Results from the IMPACT trial.
Wright TC; Stoler MH; Ranger-Moore J; Fang Q; Volkir P; Safaeian M; Ridder R
Int J Cancer; 2022 Feb; 150(3):461-471. PubMed ID: 34536311
[TBL] [Abstract][Full Text] [Related]
7. Clinical Evaluation of Human Papillomavirus Screening With p16/Ki-67 Dual Stain Triage in a Large Organized Cervical Cancer Screening Program.
Wentzensen N; Clarke MA; Bremer R; Poitras N; Tokugawa D; Goldhoff PE; Castle PE; Schiffman M; Kingery JD; Grewal KK; Locke A; Kinney W; Lorey TS
JAMA Intern Med; 2019 Jul; 179(7):881-888. PubMed ID: 31081870
[TBL] [Abstract][Full Text] [Related]
8. Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial.
Wright TC; Behrens CM; Ranger-Moore J; Rehm S; Sharma A; Stoler MH; Ridder R
Gynecol Oncol; 2017 Jan; 144(1):51-56. PubMed ID: 28094038
[TBL] [Abstract][Full Text] [Related]
9. P16/Ki-67 Dual Staining in Positive Human Papillomavirus DNA Testing for Predictive Diagnosis of Abnormal Cervical Lesions in Northeastern Thai Women.
Aromseree S; Wongjumpa W; Ekalaksananan T; Temtanakitpaisan A; Kleebkaow P; Srisathaporn S; Tongchai P; Pientong C
Asian Pac J Cancer Prev; 2022 Oct; 23(10):3405-3411. PubMed ID: 36308365
[TBL] [Abstract][Full Text] [Related]
10. [Effectiveness of Different Testing Strategies Applied for Cervical Cancer Screening in Shuangliu District, Chengdu City].
Zeng X; Li J; Kang LN; Yan LP; He Z; Liao GD; Xi MR; Chen MY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Sep; 53(5):896-903. PubMed ID: 36224694
[TBL] [Abstract][Full Text] [Related]
11. Approaches to triage optimization in HPV primary screening: Extended genotyping and p16/Ki-67 dual-stained cytology-Retrospective insights from ATHENA.
Stoler MH; Baker E; Boyle S; Aslam S; Ridder R; Huh WK; Wright TC
Int J Cancer; 2020 May; 146(9):2599-2607. PubMed ID: 31490545
[TBL] [Abstract][Full Text] [Related]
12. Dual staining for p16/Ki67 is a more specific test than cytology for triage of HPV-positive women.
Areán-Cuns C; Mercado-Gutiérrez M; Paniello-Alastruey I; Mallor-Giménez F; Córdoba-Iturriagagoitia A; Lozano-Escario M; Santamaria-Martínez M
Virchows Arch; 2018 Nov; 473(5):599-606. PubMed ID: 30094492
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of p16/Ki67 immunostaining in the triage of women referred to colposcopy.
Ordi J; Sagasta A; Munmany M; Rodríguez-Carunchio L; Torné A; del Pino M
Cancer Cytopathol; 2014 Mar; 122(3):227-35. PubMed ID: 24757722
[TBL] [Abstract][Full Text] [Related]
14. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of different triage strategies for human papillomavirus positivity in an Italian screening population.
Gustinucci D; Benevolo M; Cesarini E; Mancuso P; Passamonti B; Giaimo MD; Corvetti R; Nofrini V; Bulletti S; Malaspina M; Tintori B; Giorgi Rossi P;
Int J Cancer; 2022 Mar; 150(6):952-960. PubMed ID: 34706093
[TBL] [Abstract][Full Text] [Related]
16. Performance of P16/Ki67 dual staining in triaging hr-HPV-positive population during cervical Cancer screening in the younger women.
Qian QP; Zhang X; Ding B; Jiang SW; Li ZM; Ren ML; Shen Y
Clin Chim Acta; 2018 Aug; 483():281-285. PubMed ID: 29758205
[TBL] [Abstract][Full Text] [Related]
17. Comparison of HPV-16 and HPV-18 Genotyping and Cytological Testing as Triage Testing Within Human Papillomavirus-Based Screening in Mexico.
Torres-Ibarra L; Cuzick J; Lorincz AT; Spiegelman D; Lazcano-Ponce E; Franco EL; Moscicki AB; Mahmud SM; Wheeler CM; Rivera-Paredez B; Hernández-López R; León-Maldonado L; Salmerón J;
JAMA Netw Open; 2019 Nov; 2(11):e1915781. PubMed ID: 31747033
[TBL] [Abstract][Full Text] [Related]
18. p16/Ki-67 dual-stained cytology used for triage in cervical cancer opportunistic screening.
Han Q; Guo H; Geng L; Wang Y
Chin J Cancer Res; 2020 Apr; 32(2):208-217. PubMed ID: 32410798
[TBL] [Abstract][Full Text] [Related]
19. Cost-Effectiveness of Primary HPV Screening Strategies and Triage With Cytology or Dual Stain for Cervical Cancer.
Tantitamit T; Khemapech N; Havanond P; Termrungruanglert W
Cancer Control; 2020; 27(1):1073274820922540. PubMed ID: 32372659
[TBL] [Abstract][Full Text] [Related]
20. Triaging HPV-positive, cytology-negative cervical cancer screening results with extended HPV genotyping and p16
Song F; Yan P; Huang X; Wang C; Qu X; Du H; Wu R
BMC Infect Dis; 2021 Apr; 21(1):400. PubMed ID: 33931022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
